22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27597245	25	Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists.	Korea Research Institute Of Chemical Technology
27140209	18	Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity.	Universit£
24992374	33	Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.	University Of Naples&Quot;Federico Ii&Quot
25452001	19	Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists.	Korea Research Institute Of Chemical Technology
24251366	78	Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.	Universit£
23453841	58	Deconstruction of sulfonamide inhibitors of the urotensin receptor (UT) and design and synthesis of benzylamine and benzylsulfone antagonists.	Boehringer Ingelheim Pharmaceuticals
15936190	2	Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.	Glaxosmithkline
19473027	21	Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.	National Institute Of Neuroscienc
19432421	31	New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.	University Of Naples Federico Ii
18768319	53	N-alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists.	Glaxosmithkline
17125276	19	Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.	University Of Rouen
19695883	9	Identification of new agonists of urotensin-II from a cyclic peptide library.	Prism Bio. Lab.
18420409	4	2-Aminomethyl piperidines as novel urotensin-II receptor antagonists.	Glaxosmithkline
18502123	68	Development of potent and selective small-molecule human Urotensin-II antagonists.	Glaxosmithkline
20043680	49	Urotensin-II receptor modulators as potential drugs.	Johnson & Johnson Pharmaceutical Research & Development
19731961	127	Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.	Johnson & Johnson Pharmaceutical Research & Development
18573659	47	Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.	Glaxosmithkline
18524591	62	Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.	Glaxosmithkline
17933531	24	Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.	Johnson & Johnson Pharmaceutical Research & Development
15801838	4	Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.	Università
11960491	22	Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.	Aventis Pharma Germany
26804375	22	Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3ß Inhibitors with Anti-inflammatory Potential.	Hamdard University (Jamia Hamdard)